SCHEMBL22014823

SCHEMBL22014823

CC(=O)N1C[C@@H]2CN(c3c(F)c(F)c(F)c(F)c3F)C[C@@H]2C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CHRNB2 P17787 3/20 0.46
CHRNA3 P32297 3/20 0.46
CHRNA4 P43681 3/20 0.46
CHRNB4 P30926 2/20 0.46
CHRNB3 Q05901 1/20 0.38
CHRNA6 Q15825 1/20 0.38
CHRNA7 P36544 1/20 0.35
AOC3 Q16853 3/20 0.35
HCRTR1 O43613 7/20 0.35
HCRTR2 O43614 7/20 0.35
NOTUM Q6P988 1/20 0.33
BTK Q06187 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
OGFRL1 Q5TC84 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22015371 0.77 NR1H2 (0.50) SMN1; SMN2AOC3
SCHEMBL25967035 0.71 AOC3 (0.45) AOC3HCRTR1HCRTR2
SCHEMBL18711481 0.69 USP2 (0.53) MEN1KMT2ACHRNB2CHRNA3CHRNA4
SCHEMBL29144277 0.69 CHRNB2 (0.58) SMN1; SMN2CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL14873797 0.69 CHRNB2 (0.58) SMN1; SMN2CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL23714408 0.69 CHRNB2 (0.58) SMN1; SMN2CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL18685434 0.69 CHRNB2 (0.58) SMN1; SMN2CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL14471289 0.69 CHRNB2 (0.58) SMN1; SMN2CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL19456200 0.68
SCHEMBL14970378 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020099886-A1 LOX INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2020-05-22 WO disclosed